We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+19.73%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$204B
AUM Growth
+$40.7B
Cap. Flow
+$14.4B
Cap. Flow %
7.02%
Top 10 Hldgs %
15.11%
Holding
4,579
New
569
Increased
2,381
Reduced
1,060
Closed
261

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$845M
2
TME icon
Tencent Music
TME
+$643M
3
BIDU icon
Baidu
BIDU
+$528M
4
TSLA icon
Tesla
TSLA
+$476M
5
AMZN icon
Amazon
AMZN
+$391M

Sector Composition

Rank Sector Weight
1 Technology 13.51%
2 Consumer Discretionary 9.39%
3 Healthcare 9.23%
4 Communication Services 7.28%
5 Financials 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXPE icon
3776
DXP Enterprises
DXPE
$2.98B
$397K ﹤0.01%
17,848
+6,328
+55% +$128K
DNB
3777
DELISTED
Dun & Bradstreet
DNB
$395K ﹤0.01%
+15,854
New +$423K
FINV
3778
FinVolution Group
FINV
$1.15B
$390K ﹤0.01%
145,988
+93,666
+179% +$200K
FVRR icon
3779
CALL
Fiverr
FVRR
$339M
$390K ﹤0.01%
+2,000
New +$362K
DCP
3780
DELISTED
DCP Midstream, LP
DCP
$387K ﹤0.01%
20,932
-4,869
-19% -$76.5K
FRPH icon
3781
FRP Holdings
FRPH
$421M
$386K ﹤0.01%
16,986
+3,074
+22% +$67.5K
IJR icon
3782
CALL
iShares Core S&P Small-Cap ETF
IJR
$112B
$386K ﹤0.01%
4,200
BLNK icon
3783
Blink Charging
BLNK
$87.9M
$384K ﹤0.01%
+8,983
New +$178K
RLMD icon
3784
Relmada Therapeutics
RLMD
$527M
$383K ﹤0.01%
11,975
+6,012
+101% +$207K
WTTR icon
3785
Select Water Solutions
WTTR
$2.61B
$382K ﹤0.01%
93,292
+17,902
+24% +$72.1K
VMD icon
3786
Viemed Healthcare
VMD
$371M
$379K ﹤0.01%
48,924
+28,691
+142% +$252K
KRO icon
3787
KRONOS Worldwide
KRO
$989M
$374K ﹤0.01%
25,065
+85
+0.3% +$1.2K
AUD
3788
DELISTED
Audacy, Inc.
AUD
$374K ﹤0.01%
151,359
+13,625
+10% +$27.8K
FROG icon
3789
JFrog
FROG
$10.8B
$373K ﹤0.01%
+5,927
New +$413K
OPCH icon
3790
Option Care Health
OPCH
$3.56B
$373K ﹤0.01%
23,767
+4,899
+26% +$72.9K
CDZI icon
3791
Cadiz
CDZI
$291M
$371K ﹤0.01%
34,856
+11,604
+50% +$116K
LEGN icon
3792
Legend Biotech
LEGN
$4.01B
$371K ﹤0.01%
+13,175
New +$379K
CNSL
3793
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$370K ﹤0.01%
75,830
+22,352
+42% +$117K
IYZ icon
3794
iShares US Telecommunications ETF
IYZ
$1.26B
$366K ﹤0.01%
+12,098
New +$350K
BBAR icon
3795
BBVA Argentina
BBAR
$3.49B
$365K ﹤0.01%
113,796
+9,416
+9% +$27.9K
DISH
3796
PUT
DELISTED
DISH Network Corp.
DISH
$365K ﹤0.01%
+11,300
New +$348K
APLT
3797
DELISTED
Applied Therapeutics
APLT
$363K ﹤0.01%
16,490
+5,659
+52% +$118K
FSZ icon
3798
First Trust Switzerland AlphaDEX Fund
FSZ
$37.5M
$363K ﹤0.01%
6,013
+945
+19% +$53.4K
HCI icon
3799
HCI Group
HCI
$2.41B
$361K ﹤0.01%
6,897
+2,174
+46% +$110K
MEUSW
3800
CALL
DELISTED
23andMe Holding Co Warrant
MEUSW
$361K ﹤0.01%
+136,102
New +$323K

Similar funds

Credit Suisse's Q4 2020 Portfolio in Review

As of Q4 2020, Credit Suisse held 4,579 positions worth $204B, up 25% from $164B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $14.4B of net new capital in Q4 2020, opening 569 new positions and adding to 2,381 existing holdings. Its largest new stake was Palantir: 6,341,206 shares worth $149M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $546M trimmed.

  • Credit Suisse's largest Q4 2020 buy was Palantir: 6,341,206 shares worth $149M.
  • Credit Suisse added most to Alibaba in Q4 2020, an estimated $845M increase.
  • Credit Suisse's biggest Q4 2020 reduction was UnitedHealth, cutting an estimated $546M.
  • Credit Suisse fully exited TD Ameritrade Holding Corp in Q4 2020, selling an estimated $260M.
  • Credit Suisse's ten largest holdings make up 15% of its $204B portfolio in Q4 2020.
  • Credit Suisse opened 569 new positions and closed 261 in Q4 2020.
  • Credit Suisse's portfolio value rose 25% quarter-over-quarter to $204B.

Based on Credit Suisse's 13F filing for Q4 2020, filed 12 Feb 2021.